Tokyo / Canberra / Memphis / Atlanta / Melbourne / London / /
Company
Research And Development Agreement CSL - CSL Limited / GISN / /
Country
Puerto Rico / United States / /
Event
FDA Phase / /
Facility
New York Medical College / National Institute of Biological Standards / United Kingdom's National Institute of Biological Standards / /
IndustryTerm
input and services / vaccine manufacturing plants / healthcare professionals / cleavage site / telephone conferences / /
MedicalCondition
production work involving seasonal influenza viruses / seasonal influenza A / inactivated seasonal human influenza / influenza vaccine viruses / seasonal epidemics / influenza H5N1 / address influenza / seasonal influenza viruses / influenza / human influenza / each hemisphere's seasonal influenza / northern and southern hemisphere influenza / particular influenza / influenza symptoms / disease / produce influenza / seasonal influenza / highly pathogenic influenza viruses / live attenuated influenza / human infections / contemporary influenza viruses / Influenza A / seasonal influenza H1N1 / how seasonal human influenza viruses / avian influenza infection / human influenza H5N1 / next influenza / another national influenza / H5N1 influenza viruses / diseases / influenza viruses / Development Introduction Influenza / best influenza / influenza B / /
Organization
World Health Organization / Food and Drug Administration / United Kingdom's National Institute of Biological Standards and Control / New York Medical College / National Influenza Centre / WHO CC / TGA WHO / National Institute of Biological Standards and Control / Australian Therapeutics Goods Administration / WHO Collaborating Centre / /
Microsoft PowerPoint - InfluenzaVaccineVirusSelectionAndDevelopment[removed]ppt